Annual report [Section 13 and 15(d), not S-K Item 405]

Revenues from Contracts and Significant Customers (Company's product revenue) (Details)

v3.26.1
Revenues from Contracts and Significant Customers (Company's product revenue) (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Revenues from Contracts and Significant Customers    
Revenue $ 61,239 $ 55,134
Other revenue 2,023 1,000
Net revenue 63,262 57,675
Emrosi    
Revenues from Contracts and Significant Customers    
Revenue 14,745 0
Qbrexza    
Revenues from Contracts and Significant Customers    
Revenue 25,014 25,114
Accutane    
Revenues from Contracts and Significant Customers    
Revenue 12,882 19,407
Foam franchise products (Amzeeq & Zilxi)    
Revenues from Contracts and Significant Customers    
Revenue 5,859 6,652
Other / legacy product revenue    
Revenues from Contracts and Significant Customers    
Revenue $ 2,739 3,961
Collaboration revenue    
Revenues from Contracts and Significant Customers    
Revenue   1,500
Related Party    
Revenues from Contracts and Significant Customers    
Revenue - related party   $ 41